Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  HealthEquity, Inc.    HQY

HEALTHEQUITY, INC.

(HQY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period January 2018 2019 2020 2021 (e) 2022 (e) 2023 (e)
Sales 230 287 532 781 831 934
EBITDA 84,7 118 196 251 272 280
Operating profit (EBIT) 54,4 77,7 77,0 38,2 89,2 161
Pre-Tax Profit (EBT) 52,2 75,8 43,2 -14,4 22,8 76,5
Net income 47,4 73,9 39,7 0,87 36,7 58,1
P/E ratio 65,7x 53,3x 114x 1 534x 103x 61,3x
EPS ( $ ) 0,77 1,17 0,58 0,03 0,44 0,75
Dividend per Share ( $ ) - - - - - -
Yield - - - - - -
Reference price ( $ ) 50,620 62,340 66,060 46,000 46,000 46,000
Announcement Date 03/19/2018
08:04pm
03/18/2019
08:04pm
03/16/2020
08:04pm
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period January 2018 2019 2020 2021 (e) 2022 (e) 2023 (e)
Debt - - 1 029 877 723 494
Finance 240 0,00 - - - -
Operating income (EBITDA) 84,7 118 196 251 272 280
Leverage
(Debt/EBITDA)
- - 5,24x 3,50x 2,66x 1,77x
Capital Expenditure 15,8 13,8 32,9 32,1 33,9 45,0
Free Cash Flow (FCF) 65,9 99,6 72,1 119 166 305
Book Value Per Share (BVPS) ( $ ) 5,69 - 14,5 15,2 17,5 20,9
Cash Flow per Share ( $ ) 1,32 1,79 1,53 2,05 3,13 4,89
Announcement Date 03/19/2018
08:04pm
03/16/2020
08:04pm
- - -
Balance Sheet Analysis
Financial data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2021e 2022e
Capitalization 3 270 M $ -
Entreprise Value (EV) 4 147 M $ 3 993 M $
Valuation 2021e 2022e
P/E ratio (Price / EPS) 1 534x 103x
Capitalization / Revenue 4,19x 3,94x
EV / Revenue 5,31x 4,99x
EV / EBITDA 16,5x 15,3x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 3,02x 2,63x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) 4,89% 10,7%
Operating Leverage (Delta EBIT / Delta Sales) - 20,8x
Net Margin (Net Profit / Revenue) 0,11% 4,42%
ROA (Net Profit / Asset) 3,16% 5,13%
ROE (Net Profit / Equities) 9,97% 11,9%
Rate of Dividend - -
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   4,11% 4,08%
Cash Flow / Sales 18,6% 26,7%
Capital Intensity (Assets / Sales) 0,04x 0,86x
Financial Leverage (Net Debt / EBITDA) 3,50x 2,66x
EPS & Dividend